BR112017011891A2 - métodos de prevenção, redução ou tratamento de degeneração macular - Google Patents

métodos de prevenção, redução ou tratamento de degeneração macular

Info

Publication number
BR112017011891A2
BR112017011891A2 BR112017011891A BR112017011891A BR112017011891A2 BR 112017011891 A2 BR112017011891 A2 BR 112017011891A2 BR 112017011891 A BR112017011891 A BR 112017011891A BR 112017011891 A BR112017011891 A BR 112017011891A BR 112017011891 A2 BR112017011891 A2 BR 112017011891A2
Authority
BR
Brazil
Prior art keywords
prevention
reduction
treatment
methods
macular degeneration
Prior art date
Application number
BR112017011891A
Other languages
English (en)
Inventor
K Mcvicar William
Original Assignee
Inotek Pharmaceuticals Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inotek Pharmaceuticals Corp filed Critical Inotek Pharmaceuticals Corp
Publication of BR112017011891A2 publication Critical patent/BR112017011891A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BR112017011891A 2014-12-03 2015-12-02 métodos de prevenção, redução ou tratamento de degeneração macular BR112017011891A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462087080P 2014-12-03 2014-12-03
PCT/US2015/063450 WO2016090005A1 (en) 2014-12-03 2015-12-02 Methods of preventing, reducing or treating macular degeneration

Publications (1)

Publication Number Publication Date
BR112017011891A2 true BR112017011891A2 (pt) 2018-07-03

Family

ID=56092394

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017011891A BR112017011891A2 (pt) 2014-12-03 2015-12-02 métodos de prevenção, redução ou tratamento de degeneração macular

Country Status (12)

Country Link
US (1) US20160158267A1 (pt)
EP (1) EP3247715A1 (pt)
JP (1) JP2018501219A (pt)
KR (1) KR20170123605A (pt)
CN (1) CN107406479A (pt)
AU (1) AU2015358576A1 (pt)
BR (1) BR112017011891A2 (pt)
CA (1) CA2967446A1 (pt)
EA (1) EA201790851A1 (pt)
IL (1) IL252394A0 (pt)
MX (1) MX2017007318A (pt)
WO (1) WO2016090005A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3119891A1 (en) * 2018-11-14 2020-05-22 Zhuhai Qiwei Bio-Technology Ltd. Animal models, screening methods, and treatment methods for intraocular diseases or disorders
EP3886852B1 (en) * 2018-12-03 2024-01-31 Smilebiotek Zhuhai Limited Octyl gallate and esters thereof of for use in the treatment and prevention of age-related macular degeneration caused by bacillus megaterium
CN111658740B (zh) * 2020-06-19 2021-09-14 南京中医药大学 具有改善年龄相关性黄斑变性的药食两用组合物及其制备方法与应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5203214B2 (ja) * 2005-11-30 2013-06-05 イノテック ファーマシューティカルズ コーポレイション プリン化合物およびその使用方法
WO2010056710A1 (en) * 2008-11-11 2010-05-20 Biovista, Inc. Compositions and methods for treating eye diseases
RS54378B1 (en) * 2009-05-01 2016-04-28 Inotek Pharmaceuticals Corporation PROCEDURE FOR REDUCING EYE PRESSURE IN PEOPLE
WO2011053569A1 (en) * 2009-10-26 2011-05-05 Inotek Pharmaceuticals Corporation Ophthalmic formulation and method of manufacture thereof
CA2784908A1 (en) * 2010-01-11 2011-07-14 Inotek Pharmaceuticals Corporation Combination, kit and method of reducing intraocular pressure
US8440639B2 (en) * 2010-03-19 2013-05-14 Inotek Pharmaceuticals Corporation Combination compositions for reducing intraocular pressure
JP2013522323A (ja) * 2010-03-19 2013-06-13 イノテック ファーマシューティカルズ コーポレイション 眼内圧を下げるためのアデノシンＡ１受容体アゴニストと非選択的β−アドレナリン受容体遮断薬との組合せ組成物
EP2569325A4 (en) * 2010-03-26 2013-10-09 Inotek Pharmaceuticals Corp METHOD FOR REDUCING INTRAOCULAR PRESSURE IN HUMANS USING N6-CYCLOPENTYLADENOSINE (CPA) DERIVATIVES OR CPA PRODRUGS
SG184223A1 (en) * 2010-03-26 2012-10-30 Inotek Pharmaceuticals Corp Adenosine compounds and their use thereof
EP2701719A4 (en) * 2011-04-28 2015-04-22 Claire Mitchell METHOD FOR TREATING MACULAR OBGENATION BY MODULATION OF P2Y12 OR P2X7 RECEPTORS
US20140275128A1 (en) * 2013-03-15 2014-09-18 Inotek Pharmaceuticals Corporation Method of providing ocular neuroprotection
MX2015013234A (es) * 2013-03-15 2016-04-15 Inotek Pharmaceuticals Corp Formulaciones oftalmicas.

Also Published As

Publication number Publication date
IL252394A0 (en) 2017-07-31
US20160158267A1 (en) 2016-06-09
KR20170123605A (ko) 2017-11-08
CA2967446A1 (en) 2016-06-09
JP2018501219A (ja) 2018-01-18
MX2017007318A (es) 2017-08-25
EP3247715A1 (en) 2017-11-29
WO2016090005A1 (en) 2016-06-09
EA201790851A1 (ru) 2017-11-30
CN107406479A (zh) 2017-11-28
AU2015358576A1 (en) 2017-06-22

Similar Documents

Publication Publication Date Title
HK1246179A1 (zh) 治療視網膜疾病的方法
GB201701673D0 (en) Methods of well treatment
EP3122414A4 (en) Venous disease treatment
ZA201700416B (en) Methods for treating or preventing ophthalmological conditions
IL250513A0 (en) Treatment of episode disorders
EP3234116A4 (en) Methods of treating tissue calcification
PT3233071T (pt) Método de tratamento ou prevenção de doenças mediadas por ras
ES2893126T8 (es) Métodos de tratamiento de afecciones oculares
BR112018000204A2 (pt) métodos de tratamento de colite
GB201410116D0 (en) Method of treatment
IL253028B (en) treatment method
IL251769A0 (en) Methods for treating eye conditions
EP3134108A4 (en) Agents and methods of treatment
GB201416832D0 (en) Methods of treatment
BR112016015712A8 (pt) método de tratamento de doenças hepáticas.
IL252394A0 (en) Methods for preventing, reducing or treating macular degeneration
GB201412010D0 (en) Treatment of hypertransaminasemia
GB201512139D0 (en) Methods of treatment
BR112016028196A2 (pt) método de inibição ou tratamento de fibrose
AU2015905220A0 (en) Methods of treatment
GB2532447B (en) Treatment of Contaminated Land
EP3139924A4 (en) Methods of treating or preventing preterm labor
EP3188744A4 (en) Methods for treatment and prevention of vascular disease
AU2015902366A0 (en) Treatment for myopia
AU2014902334A0 (en) Treatment for myopia

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]